Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2016-04-28
|
Validive® (clonidine Lauriad®) |
chemoradiation therapy induced oral mucositis in patients with head and neck cancer |
2 |
Onxeo - previously known as Bioalliance Pharma (France) |
Cancer - Oncology |
2016-04-28
|
ALKS 7119 |
treatment of agitation in patients with Alzheimer’s disease, major depressive disorder (MDD) and other central nervous system (CNS) indications |
1 |
Alkermes (Ireland) |
Neurodegenerative diseases - CNS diseases |
2016-04-28
|
Rayaldee™ ( calcifediol - vitamin D prohormone) |
secondary hyperparathyroidism (SHPT) |
|
Opko Health (USA - Fl) |
Hormonal diseases - Endocrine diseases |
2016-04-28
|
SHP465 (triple-bead mixed amphetamine salts - MAS) |
Attention-Deficit Hyperactivity Disorder (ADHD) |
3 |
Shire (UK - USA) |
CNS diseases - Mental diseases - Neurological diseases |
2016-04-28
|
relacorilant (CORT125134) |
solid tumors |
preclinical |
Corcept Therapeutics (USA - CA) |
Cancer - Oncology |
2016-04-27
|
AT132 |
X-linked myotubular myopathy (XLMTM) |
preclinical |
Audentes Therapeutics (USA - CA) Genethon (France) |
Rare diseases - Genetic diseases - Neuromuscular diseases |
2016-04-27
|
AT132 |
X-linked Myotubular Myopathy (XLMTM) |
preclinical |
Audentes Therapeutics (USA - CA) |
Rare diseases - Genetic diseases - Neuromuscular diseases |
2016-04-27
|
INO-8000 |
hepatitis C |
1 |
Inovio Pharmaceuticals (USA - PA) |
Infectious diseases |
2016-04-27
|
sublingual house dust mite and Japanese cedar pollen immunotherapy tablets (STAGR120) |
seasonal allergic rhinitis induced by Japanese Cedar pollen |
2 |
Shionogi (Japan) Stallergenes Greer (UK) |
Allergic diseases - Immunological diseases - Respiratory diseases |
2016-04-27
|
Jetrea® (ocriplasmin) |
|
|
Thrombogenics (Belgium) |
Ophtalmological diseases |
2016-04-27
|
Paclical®/Apealea® (paclitaxel) |
epithelial ovarian cancer |
3 |
Oasmia Pharmaceutical (Sweden) |
Cancer - Oncology |
2016-04-27
|
glembatumumab vedotin (CDX-011) |
squamous cell carcinoma of the lung |
1-2 |
Celldex Therapeutics (USA - NJ) PrECOG (USA - PA) |
Cancer - Oncology |
2016-04-27
|
BioChaperone Lispro® |
type 2 diabetes |
1b |
Adocia (France) Eli Lilly (USA - IN) |
Metabolic diseases |
2016-04-26
|
recAP - recombinant alkaline phosphatase |
sepsis-associated Acute Kidney Injury (AKI) |
2 |
Am-Pharma (The Netherlands) |
Infectious diseases - Kidney diseases |
2016-04-26
|
AZP-531 (unacylated ghrelin analog) |
Prader-Willi syndrome |
2 |
Alize Pharma (France) |
Rare diseases - Genetic diseases |
2016-04-26
|
brilacidin |
acute bacterial skin and skin structure infections (ABSSSI) |
3 |
Cellceutix (USA - MA) now Innovation Pharmaceuticals (USA - MA) |
Infectious diseases |
2016-04-25
|
TSR-022 |
|
1 |
Tesaro (US - MA) |
Cancer - Oncology |
2016-04-25
|
GLP-1 (glucagon-like peptide 1) and glucagon receptors |
|
|
Heptares Therapeutics (UK), a wholly-owned subsidiary of Sosei Group (Japan) |
Metabolic diseases |
2016-04-25
|
SelectMDx™ for Prostate Cancer |
prostate cancer |
|
MDxHealth (Belgium) |
Cancer - Oncology |
2016-04-22
|
rAAV2-CB-hRPE65 |
Leber congenital amaurosis (LCA), severe early-childhood-onset retinal degeneration (SECORD) |
1-2 |
AGTC (USA - FL) |
Rare diseases - Genetic diseases - Ophtalmological diseases |